Annual report
4368.TEDINET S100YEIS
Period2025-04-01 → 2026-03-31
Filed2026-06-19
StandardJapan GAAP
ConsolidatedYes
Data checks24 of 24 passed
Key figures · 148
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥76.9bn | 2025-04-01 → 2026-03-31 | Cons. | Net sales |
| Revenue | ¥69.5bn | 2024-04-01 → 2025-03-31 | Cons. | Net sales |
| Revenue | ¥59.0bn | 2023-04-01 → 2024-03-31v | Cons. | Net sales (5-year summary) |
| Revenue | ¥68.5bn | 2022-04-01 → 2023-03-31v | Cons. | Net sales (5-year summary) |
| Revenue | ¥55.8bn | 2021-04-01 → 2022-03-31v | Cons. | Net sales (5-year summary) |
| Operating income | ¥18.9bn | 2025-04-01 → 2026-03-31 | Cons. | Operating income |
| Operating income | ¥16.2bn | 2024-04-01 → 2025-03-31 | Cons. | Operating income |
| Ordinary income | ¥19.6bn | 2025-04-01 → 2026-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥16.6bn | 2024-04-01 → 2025-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥11.9bn | 2023-04-01 → 2024-03-31v | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥19.7bn | 2022-04-01 → 2023-03-31v | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥15.5bn | 2021-04-01 → 2022-03-31v | Cons. | Ordinary income loss (5-year summary) |
| Profit before tax | ¥19.5bn | 2025-04-01 → 2026-03-31 | Cons. | Income before income taxes |
| Profit before tax | ¥16.3bn | 2024-04-01 → 2025-03-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥14.3bn | 2025-04-01 → 2026-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥11.6bn | 2024-04-01 → 2025-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥8.3bn | 2023-04-01 → 2024-03-31v | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥14.1bn | 2022-04-01 → 2023-03-31v | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥10.9bn | 2021-04-01 → 2022-03-31v | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income | ¥14.3bn | 2025-04-01 → 2026-03-31 | Cons. | Profit loss |
| Net income | ¥11.6bn | 2024-04-01 → 2025-03-31 | Cons. | Profit loss |
| Total assets | ¥152.3bn | at 2026-03-31 | Cons. | Assets |
| Total assets | ¥141.5bn | at 2025-03-31 | Cons. | Assets |
| Total assets | ¥133.7bn | at 2024-03-31v | Cons. | Total assets (5-year summary) |
| Total assets | ¥113.5bn | at 2023-03-31v | Cons. | Total assets (5-year summary) |
| Total assets | ¥92.0bn | at 2022-03-31v | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥35.0bn | at 2026-03-31 | Cons. | Liabilities |
| Total liabilities | ¥37.5bn | at 2025-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥117.2bn | at 2026-03-31 | Cons. | Net assets |
| Net assets / equity | ¥104.0bn | at 2025-03-31 | Cons. | Net assets |
| Net assets / equity | ¥95.0bn | at 2024-03-31v | Cons. | Net assets |
| Net assets / equity | ¥87.5bn | at 2023-03-31v | Cons. | Net assets (5-year summary) |
| Net assets / equity | ¥75.3bn | at 2022-03-31v | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥41.0bn | at 2026-03-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥31.3bn | at 2025-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥37.9bn | at 2026-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥29.2bn | at 2025-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥29.5bn | at 2024-03-31v | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥22.4bn | at 2023-03-31v | Cons. | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥23.5bn | at 2022-03-31v | Cons. | Cash and cash equivalents (5-year summary) |
| Operating cash flow | ¥24.8bn | 2025-04-01 → 2026-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥22.7bn | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥7.1bn | 2023-04-01 → 2024-03-31v | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥13.9bn | 2022-04-01 → 2023-03-31v | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥10.2bn | 2021-04-01 → 2022-03-31v | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Investing cash flow | −¥11.1bn | 2025-04-01 → 2026-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥20.5bn | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥18.6bn | 2023-04-01 → 2024-03-31v | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥13.4bn | 2022-04-01 → 2023-03-31v | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥9.4bn | 2021-04-01 → 2022-03-31v | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Financing cash flow | −¥5.9bn | 2025-04-01 → 2026-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥2.4bn | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥17.7bn | 2023-04-01 → 2024-03-31v | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥2.1bn | 2022-04-01 → 2023-03-31v | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥2.9bn | 2021-04-01 → 2022-03-31v | Cons. | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥135.28 | 2025-04-01 → 2026-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥109.89 | 2024-04-01 → 2025-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥78.9 | 2023-04-01 → 2024-03-31v | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥133.63 | 2022-04-01 → 2023-03-31v | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥102.69 | 2021-04-01 → 2022-03-31v | Cons. | Basic earnings loss per share (5-year summary) |
| Net assets per share | ¥1,107.94 | at 2026-03-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥983.72 | at 2025-03-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥898.59 | at 2024-03-31v | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥827.6 | at 2023-03-31v | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥712.21 | at 2022-03-31v | Cons. | Net assets per share (5-year summary) |
| Equity ratio | 77.0% | at 2026-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 73.5% | at 2025-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 71.0% | at 2024-03-31v | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 77.1% | at 2023-03-31v | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 81.8% | at 2022-03-31v | Cons. | Equity to asset ratio (5-year summary) |
| ROE | 12.9% | 2025-04-01 → 2026-03-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 11.7% | 2024-04-01 → 2025-03-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 9.1% | 2023-04-01 → 2024-03-31v | Cons. | Rate of return on equity (5-year summary) |
| ROE | 17.4% | 2022-04-01 → 2023-03-31v | Cons. | Rate of return on equity (5-year summary) |
| ROE | 15.4% | 2021-04-01 → 2022-03-31v | Cons. | Rate of return on equity (5-year summary) |
| Employees | 956 | at 2026-03-31 | Cons. | Number of employees |
| Employees | 915 | at 2025-03-31 | Cons. | Number of employees |
| Employees | 892 | at 2024-03-31v | Cons. | Number of employees |
| Employees | 859 | at 2023-03-31v | Cons. | Number of employees |
| Employees | 805 | at 2022-03-31v | Cons. | Number of employees |
| Revenue | ¥64.1bn | 2025-04-01 → 2026-03-31 | Standalone | Net sales |
| Revenue | ¥57.5bn | 2024-04-01 → 2025-03-31 | Standalone | Net sales |
| Revenue | ¥47.8bn | 2023-04-01 → 2024-03-31v | Standalone | Net sales (5-year summary) |
| Revenue | ¥57.0bn | 2022-04-01 → 2023-03-31v | Standalone | Net sales (5-year summary) |
| Revenue | ¥46.2bn | 2021-04-01 → 2022-03-31v | Standalone | Net sales (5-year summary) |
| Operating income | ¥15.4bn | 2025-04-01 → 2026-03-31 | Standalone | Operating income |
| Operating income | ¥13.0bn | 2024-04-01 → 2025-03-31 | Standalone | Operating income |
| Ordinary income | ¥19.0bn | 2025-04-01 → 2026-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥14.7bn | 2024-04-01 → 2025-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥10.4bn | 2023-04-01 → 2024-03-31v | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥17.6bn | 2022-04-01 → 2023-03-31v | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥14.0bn | 2021-04-01 → 2022-03-31v | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | ¥18.9bn | 2025-04-01 → 2026-03-31 | Standalone | Income before income taxes |
| Profit before tax | ¥14.4bn | 2024-04-01 → 2025-03-31 | Standalone | Income before income taxes |
| Net income | ¥14.6bn | 2025-04-01 → 2026-03-31 | Standalone | Profit loss |
| Net income | ¥10.9bn | 2024-04-01 → 2025-03-31 | Standalone | Profit loss |
| Net income | ¥7.7bn | 2023-04-01 → 2024-03-31v | Standalone | Net income loss (5-year summary) |
| Net income | ¥13.0bn | 2022-04-01 → 2023-03-31v | Standalone | Net income loss (5-year summary) |
| Net income | ¥10.2bn | 2021-04-01 → 2022-03-31v | Standalone | Net income loss (5-year summary) |
| Total assets | ¥137.9bn | at 2026-03-31 | Standalone | Assets |
| Total assets | ¥128.5bn | at 2025-03-31 | Standalone | Assets |
| Total assets | ¥121.5bn | at 2024-03-31v | Standalone | Total assets (5-year summary) |
| Total assets | ¥103.1bn | at 2023-03-31v | Standalone | Total assets (5-year summary) |
| Total assets | ¥84.0bn | at 2022-03-31v | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥34.0bn | at 2026-03-31 | Standalone | Liabilities |
| Total liabilities | ¥36.5bn | at 2025-03-31 | Standalone | Liabilities |
| Net assets / equity | ¥103.9bn | at 2026-03-31 | Standalone | Net assets |
| Net assets / equity | ¥92.0bn | at 2025-03-31 | Standalone | Net assets |
| Net assets / equity | ¥83.6bn | at 2024-03-31v | Standalone | Net assets |
| Net assets / equity | ¥78.1bn | at 2023-03-31v | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥67.4bn | at 2022-03-31v | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥31.7bn | at 2026-03-31 | Standalone | Cash and deposits |
| Cash and deposits | ¥23.8bn | at 2025-03-31 | Standalone | Cash and deposits |
| EPS (basic) | ¥138.4 | 2025-04-01 → 2026-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥102.59 | 2024-04-01 → 2025-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥73.17 | 2023-04-01 → 2024-03-31v | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥123.35 | 2022-04-01 → 2023-03-31v | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥95.82 | 2021-04-01 → 2022-03-31v | Standalone | Basic earnings loss per share (5-year summary) |
| Dividend per share | ¥82 | 2025-04-01 → 2026-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥73 | 2024-04-01 → 2025-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥66 | 2023-04-01 → 2024-03-31v | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥63 | 2022-04-01 → 2023-03-31v | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥55 | 2021-04-01 → 2022-03-31v | Standalone | Dividend paid per share (5-year summary) |
| Net assets per share | ¥981.95 | at 2026-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥870.04 | at 2025-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥791 | at 2024-03-31v | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥738.63 | at 2023-03-31v | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥637.72 | at 2022-03-31v | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 75.3% | at 2026-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 71.6% | at 2025-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 68.8% | at 2024-03-31v | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 75.8% | at 2023-03-31v | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 80.3% | at 2022-03-31v | Standalone | Equity to asset ratio (5-year summary) |
| ROE | 14.9% | 2025-04-01 → 2026-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 12.3% | 2024-04-01 → 2025-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 9.6% | 2023-04-01 → 2024-03-31v | Standalone | Rate of return on equity (5-year summary) |
| ROE | 17.9% | 2022-04-01 → 2023-03-31v | Standalone | Rate of return on equity (5-year summary) |
| ROE | 15.9% | 2021-04-01 → 2022-03-31v | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 35,511,000 | at 2026-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 35,511,000 | at 2025-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 35,511,000 | at 2024-03-31v | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 35,511,000 | at 2023-03-31v | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 35,511,000 | at 2022-03-31v | Standalone | Total number of issued shares (5-year summary) |
| Employees | 623 | at 2026-03-31 | Standalone | Number of employees |
| Employees | 588 | at 2025-03-31 | Standalone | Number of employees |
| Employees | 567 | at 2024-03-31v | Standalone | Number of employees |
| Employees | 538 | at 2023-03-31v | Standalone | Number of employees |
| Employees | 491 | at 2022-03-31v | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 48
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | capex | 2025-04-01 → 2026-03-31 | ¥127m |
| Reconciling Itemsreconciling | depreciation | 2025-04-01 → 2026-03-31 | ¥203m |
| Reconciling Itemsreconciling | segment assets | at 2026-03-31 | ¥39.1bn |
| Reconciling Itemsreconciling | segment profit | 2025-04-01 → 2026-03-31 | −¥2.4bn |
| Electronic Materials Business Unitreportable segment | capex | 2025-04-01 → 2026-03-31 | ¥7.9bn |
| Electronic Materials Business Unitreportable segment | depreciation | 2025-04-01 → 2026-03-31 | ¥9.1bn |
| Electronic Materials Business Unitreportable segment | employees | at 2026-03-31 | 384 pure |
| Electronic Materials Business Unitreportable segment | revenue | 2025-04-01 → 2026-03-31 | ¥41.5bn |
| Electronic Materials Business Unitreportable segment | revenue external | 2025-04-01 → 2026-03-31 | ¥41.5bn |
| Electronic Materials Business Unitreportable segment | segment assets | at 2026-03-31 | ¥72.7bn |
| Electronic Materials Business Unitreportable segment | segment profit | 2025-04-01 → 2026-03-31 | ¥15.9bn |
| Life Science Business Unitreportable segment | capex | 2025-04-01 → 2026-03-31 | ¥2.7bn |
| Life Science Business Unitreportable segment | depreciation | 2025-04-01 → 2026-03-31 | ¥1.6bn |
| Life Science Business Unitreportable segment | employees | at 2026-03-31 | 516 pure |
| Life Science Business Unitreportable segment | revenue | 2025-04-01 → 2026-03-31 | ¥35.4bn |
| Life Science Business Unitreportable segment | revenue external | 2025-04-01 → 2026-03-31 | ¥35.4bn |
| Life Science Business Unitreportable segment | segment assets | at 2026-03-31 | ¥40.4bn |
| Life Science Business Unitreportable segment | segment profit | 2025-04-01 → 2026-03-31 | ¥5.3bn |
| —segment total | capex | 2025-04-01 → 2026-03-31 | ¥10.7bn |
| —segment total | depreciation | 2025-04-01 → 2026-03-31 | ¥10.7bn |
| —segment total | revenue | 2025-04-01 → 2026-03-31 | ¥76.9bn |
| —segment total | revenue external | 2025-04-01 → 2026-03-31 | ¥76.9bn |
| —segment total | segment assets | at 2026-03-31 | ¥113.1bn |
| —segment total | segment profit | 2025-04-01 → 2026-03-31 | ¥21.2bn |
| Reconciling Itemsreconciling | capex | 2024-04-01 → 2025-03-31 | ¥1.6bn |
| Reconciling Itemsreconciling | depreciation | 2024-04-01 → 2025-03-31 | ¥218m |
| Reconciling Itemsreconciling | segment assets | at 2025-03-31 | ¥30.3bn |
| Reconciling Itemsreconciling | segment profit | 2024-04-01 → 2025-03-31 | −¥2.2bn |
| Electronic Materials Business Unitreportable segment | capex | 2024-04-01 → 2025-03-31 | ¥14.6bn |
| Electronic Materials Business Unitreportable segment | depreciation | 2024-04-01 → 2025-03-31 | ¥6.5bn |
| Electronic Materials Business Unitreportable segment | revenue | 2024-04-01 → 2025-03-31 | ¥33.2bn |
| Electronic Materials Business Unitreportable segment | revenue external | 2024-04-01 → 2025-03-31 | ¥33.2bn |
| Electronic Materials Business Unitreportable segment | segment assets | at 2025-03-31 | ¥72.6bn |
| Electronic Materials Business Unitreportable segment | segment profit | 2024-04-01 → 2025-03-31 | ¥13.2bn |
| Life Science Business Unitreportable segment | capex | 2024-04-01 → 2025-03-31 | ¥1.4bn |
| Life Science Business Unitreportable segment | depreciation | 2024-04-01 → 2025-03-31 | ¥1.6bn |
| Life Science Business Unitreportable segment | revenue | 2024-04-01 → 2025-03-31 | ¥36.3bn |
| Life Science Business Unitreportable segment | revenue external | 2024-04-01 → 2025-03-31 | ¥36.3bn |
| Life Science Business Unitreportable segment | segment assets | at 2025-03-31 | ¥38.5bn |
| Life Science Business Unitreportable segment | segment profit | 2024-04-01 → 2025-03-31 | ¥5.3bn |
| —segment total | capex | 2024-04-01 → 2025-03-31 | ¥15.9bn |
| —segment total | depreciation | 2024-04-01 → 2025-03-31 | ¥8.1bn |
| —segment total | revenue | 2024-04-01 → 2025-03-31 | ¥69.5bn |
| —segment total | revenue external | 2024-04-01 → 2025-03-31 | ¥69.5bn |
| —segment total | segment assets | at 2025-03-31 | ¥111.2bn |
| —segment total | segment profit | 2024-04-01 → 2025-03-31 | ¥18.5bn |
| Electronic Materials Business Unitreportable segment | employees | at 2026-03-31 | 357 pure |
| Life Science Business Unitreportable segment | employees | at 2026-03-31 | 210 pure |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 1,698
| Item | Context | Value | Unit |
|---|---|---|---|
| Number of shares held | CurrentYearInstant_No10MajorShareholdersMember | 708000 | |
| Shareholding ratio | CurrentYearInstant_No10MajorShareholdersMember | 0.0201 | |
| Number of shares held | CurrentYearInstant | 22671000 | |
| Shareholding ratio | CurrentYearInstant | 0.6429 | |
| Number of shares issued shares voting rights | CurrentYearInstant_SharesWithNoVotingRightsMember | － | |
| Number of shares issued shares voting rights | CurrentYearInstant_SharesWithRestrictedVotingRightsTreasurySharesEtcMember | － | |
| Number of shares issued shares voting rights | CurrentYearInstant_SharesWithRestrictedVotingRightsOtherMember | － | |
| Number of voting rights issued shares voting rights | CurrentYearInstant_SharesWithRestrictedVotingRightsOtherMember | － | |
| Number of shares issued shares voting rights | CurrentYearInstant_OrdinarySharesTreasurySharesSharesWithFullVotingRightsTreasurySharesEtcMember | 245500 | |
| Number of shares issued shares voting rights | CurrentYearInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember | 35239500 | |
| Number of voting rights issued shares voting rights | CurrentYearInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember | 352395 | |
| Number of shares issued shares voting rights | CurrentYearInstant_OrdinarySharesSharesLessThanOneUnitMember | 26000 | |
| Number of shares issued shares voting rights | CurrentYearInstant | 35511000 | |
| Number of voting rights issued shares voting rights | CurrentYearInstant | 352395 | |
| Number of shares held in own name treasury shares etc | CurrentYearInstant_Row1Member | 245500 | |
| Number of shares held in others names treasury shares etc | CurrentYearInstant_Row1Member | － | |
| Total number of shares held treasury shares etc | CurrentYearInstant_Row1Member | 245500 | |
| Shareholding ratio treasury shares etc | CurrentYearInstant_Row1Member | 0.0069 | |
| Number of shares held in own name treasury shares etc | CurrentYearInstant | 245500 | |
| Number of shares held in others names treasury shares etc | CurrentYearInstant | － | |
| Total number of shares held treasury shares etc | CurrentYearInstant | 245500 | |
| Shareholding ratio treasury shares etc | CurrentYearInstant | 0.0069 | |
| Total amount of dividends dividends of surplus | FilingDateInstant_Row1Member | 1445885000 | JPY |
| Dividend per share dividends of surplus | FilingDateInstant_Row1Member | 41 | |
| Total amount of dividends dividends of surplus | FilingDateInstant_Row2Member | 1445883000 | JPY |
| Dividend per share dividends of surplus | FilingDateInstant_Row2Member | 41 | |
| Number of male directors and other officers | FilingDateInstant | 9 | |
| Number of female directors and other officers | FilingDateInstant | 2 | |
| Ratio of female directors and other officers | FilingDateInstant | 0.182 | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E01056-000FujiokaMisakoMember | 111000 | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E01056-000SugitaShinichiMember | 50000 | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E01056-000MasaujiHaruoMember | 94000 | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E01056-000FujiokaAtsushiMember | 74000 | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E01056-000SugimotoMotokiMember | 17000 | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E01056-000HiroyukiItoMember | 8000 | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E01056-000NorikazuMiyamotoMember | 11000 | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E01056-000HyakushimaHakaruMember | 0 | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E01056-000HirataFumiakiMember | 4000 | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E01056-000EguroSayakaMember | － | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E01056-000KeiTakeuchiMember | 0 | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant | 373000 | |
| Number of male directors and other officers proposal | FilingDateInstant | 10 | |
| Number of female directors and other officers proposal | FilingDateInstant | 2 | |
| Ratio of female directors and other officers proposal | FilingDateInstant | 0.167 | |
| Number of shares held ordinary shares information about directors and corporate auditors proposal | FilingDateInstant_jpcrp030000-asr_E01056-000FujiokaMisakoMember | 111000 | |
| Number of shares held ordinary shares information about directors and corporate auditors proposal | FilingDateInstant_jpcrp030000-asr_E01056-000SugitaShinichiMember | 50000 | |
| Number of shares held ordinary shares information about directors and corporate auditors proposal | FilingDateInstant_jpcrp030000-asr_E01056-000MasaujiHaruoMember | 94000 | |
| Number of shares held ordinary shares information about directors and corporate auditors proposal | FilingDateInstant_jpcrp030000-asr_E01056-000FujiokaAtsushiMember | 74000 | |
| Number of shares held ordinary shares information about directors and corporate auditors proposal | FilingDateInstant_jpcrp030000-asr_E01056-000SugimotoMotokiMember | 17000 | |
| Number of shares held ordinary shares information about directors and corporate auditors proposal | FilingDateInstant_jpcrp030000-asr_E01056-000HiroyukiItoMember | 8000 |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 24 of 24 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |